Capricor Therapeutics, Inc. (CAPR) vs YD Bio Limited (YDES)

Capricor Therapeutics, Inc. CAPR 8.89 +7.89%
YD Bio Limited YDES 6.98 +9.06%

Capricor Therapeutics, Inc. and YD Bio Limited are both Biotechnology companies. Capricor Therapeutics, Inc. and YD Bio Limited are of similar size ($479.1M and $453.0M).

Metric	CAPR	YDES	Biotechnology median
P/E	n/m	—	10.64
P/S	21.17	—	9.59
P/B	1.92	—	2.15
Price to free cash flow	3.60	—	26.07
EV/EBITDA	n/m	—	0.65
EV/Sales	11.13	—	9.45
Earnings yield	(30.10%)	—	(34.69%)
Free cash flow yield	27.76%	—	(24.02%)

Metric	CAPR	YDES	Biotechnology median
Gross margin	100.00%	—	65.59%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(73.70%)	—	(51.96%)
Return on assets	(51.53%)	—	(46.06%)
Return on invested capital	(1,019.73%)	—	0.00%

Metric	CAPR	YDES	Biotechnology median
Revenue growth (TTM)	(11.55%)	—	4.59%
EPS growth (last fiscal year)	(96.52%)	—	29.88%
Revenue growth, 5-year CAGR	85.83%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CAPR	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	7.35	—	4.86
Net debt to EBITDA	2.99	—	1.01

Metric	CAPR	YDES	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	CAPR	YDES	Biotechnology median
Market cap	479.07m	453.04m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack